CYPB - Cypress BioScience Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CYPB - Cypress BioScience

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Joel who wrote (68)	1/23/1998 6:34:00 PM
From: Ben Geh	Read Replies (1) of 586

Joel: I am really more interested in the long term price which IMHO should reach the some multiples of 10 in good time and I believe this will become reality in a matter of time. Right now I am really interested in their commerciallization plan for FDA approval followed by mass production. Since the PROSORBA(R) column is already approved for CYPB other product usage, I believe approval for rheumatoid arthritis would be quick and swift especially when their Phase III trials had been so impressive as to be terminated one year in advance. I am especially excited by the RA's $2 billion market which provides CYPB stock price with incredible potential for moving into the 10 multiples. I am also excited by their Phase II trial for platelet infusion which have a worldwide market of $1.5 billion which increases the stock's potential to unimaginable heights in the future. At the rate the stock price is behaving, I believe there are people who do have the same view as me. At the moment this stock have reportedly 12 institutional holders. I believe we are going to see more at the next report. Good luck to all!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next